International General Insurance Reports Mixed FY25 Results, Strong Book Value Growth, and Declares Dividend
IGIC sits 29% above its 52-week low of $20.82 on elevated volume (1.8× avg).
Summary
International General Insurance Holdings Ltd. reported mixed financial results for Q4 and full year 2025, with a decline in full-year net income and premiums but strong growth in book value per share and significant share repurchases.
Key Events · Earnings and Guidance · IGIC
-
Full Year 2025 Performance
Net income decreased to $127.2 million from $135.2 million in 2024, and gross written premiums declined to $666.7 million from $700.1 million.
-
Q4 2025 Performance
Net income increased by 7.7% to $32.3 million, with diluted EPS rising to $0.76 from $0.65 in the prior year quarter.
-
Book Value Growth
Book value per share grew by 13.9% to $16.91 at December 31, 2025, compared to $14.85 at December 31, 2024.
-
Shareholder Returns
The company repurchased 2,635,510 common shares for $61.9 million during 2025 and declared an ordinary common share dividend of $0.05 per share.
Analysis · IGIC · Finance
The company delivered a mixed financial performance for 2025, marked by a decline in full-year net income and gross written premiums, and a higher combined ratio indicating reduced underwriting profitability. However, Q4 net income and EPS showed growth. A key highlight is the substantial 13.9% increase in book value per share to $16.91, demonstrating strong underlying value creation. The company also returned over $108 million to shareholders through dividends and significant share repurchases totaling $61.9 million, which represents a substantial portion of its market capitalization. This capital return strategy, alongside the book value growth, provides a positive signal to investors, especially as the stock trades near its 52-week high. Investors will monitor future premium growth and underwriting margins.
At the time of this filing, IGIC was trading at $26.80 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $20.82 to $27.76. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.